Patient in Focus works closely, both abroad and at home with a number of organizations, authorities, the pharmaceutical industry and patient associations.

Patient in Focus is registered with the European Commission and can participate in research projects throughout Europe.

Patient in Focus may include direct and indirect industry support but is independent of this support. The pharmaceutical industry does not sit on the Board of Patient in Focus and has no influence on the organization. Patient in Focus is compatible with foundation support with established criteria for openness and independence. If Patient in Focus receives more than five percent, it enters into a dialogue with the board’s committee with a view to assessing the project’s openness.

Our Partners

Manigrip and Patient in Focus
MarcusEvans and Patient in Focus
GE Healthcare and Patient in Focus
VMLY&R and Patient in Focus
Bayer PIE and Patient in Focus
PharmaLedger and Patient in Focus
Velliv Foreningen and Patient in Focus
Life with rheumatoid arthritis and Patient in Focus
Lupus and Patient in Focus